Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07023887 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Prospective Study of EXErcise Regimens After Treatment for Breast Cancer for Hypertrophy and Conditioning

Study acronym: EXERT-BCHC
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 9 months later Jul 15, 2026 → May 3, 2027
See other at-risk trials from Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Jul 15, 2026 to May 3, 2027 Show 5 more changesShow less
    • Study completion pushed from Oct 15, 2026 to May 3, 2027
    • Interventions: 5/5/5 Cluster Set Training Regimen (Other), 6-12-25 Training Regimen (Other), 8x8 Training Regimen (Other), Double Training Regimen (Other) to 5/5/5 Cluster Set Training Regimen (Other), 6-12-25 Training Regimen (Other), 8x8 Training Regimen (Other), Double Training Regimen (Other)
    • Eligibility criteria expanded, about 12 words
    • Secondary endpoints: details revised at 1 of 2 entries
    • Site contact updated
  2. Primary completion date: Nov 14, 2025 to Jul 15, 2026
    • Study completion date: May 14, 2026 to Oct 15, 2026
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study investigates the impact of four standard of care, monitored group exercise regimens (resistance training) on conditioning and hypertrophy in women previously treated for breast cancer. The study will compare two conditioning regimens (6-12-25 and 8x8) and two hypertrophy regimens (5/5/5 cluster sets and double training) to assess changes in VO2 max, muscle mass, and fat mass.
Trial Details
NCT Number NCT07023887
Lead Sponsor Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Conditions
(from sponsor)		 Cancer, Breast Cancer
Related terms Breast Neoplasms, Motor Activity, Neoplasms
Enrollment 15 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov